cilostazol has been researched along with MS (Multiple Sclerosis) in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol is a hopeful choice for the treatment of multiple sclerosis." | 1.35 | Selective phosphodiesterase-3 inhibitor cilostazol ameliorates experimental autoimmune encephalomyelitis. ( Kureshiro, J; Kusunoki, S; Miyamoto, K; Tanaka, N, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kureshiro, J | 1 |
| Miyamoto, K | 1 |
| Tanaka, N | 1 |
| Kusunoki, S | 1 |
| Yoshikawa, M | 1 |
| Suzumura, A | 1 |
| Tamaru, T | 1 |
| Takayanagi, T | 1 |
| Sawada, M | 1 |
2 other studies available for cilostazol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Selective phosphodiesterase-3 inhibitor cilostazol ameliorates experimental autoimmune encephalomyelitis.
Topics: Animals; Cilostazol; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Glycoprote | 2009 |
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamo | 1999 |